Floatz logo

/Pn-196,444

Lymphoma, Malignant

PfizerPhase 3Dormant
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

289 Active assets in the Lymphoma, Malignant cohort.

Asset / SponsorPhaseRating
VINBLASTINE
Intensity Therapeutics, Inc.
Phase 4BBB
CHLOROPTIC-P S.O.P. COMPONENT PREDNISOLONE
The Lymphoma Academic Research Organisation
Phase 4BBB
BLEOMYCIN
Shandong Provincial Hospital
Phase 4BB
VINCRISTINE SULFATE
Inhye Ahn
Phase 3BB
FILGRASTIM
M.D. Anderson Cancer Center
Phase 4BB

View all 50 →

Same molecule, other indications

/Pn-196,444 is also rated in:

thrombocytopeniaDormant
BB
Indicative ·
66 / 100
View asset →
Hodgkins lymphomaDormant
B
Indicative ·
62 / 100
View asset →
non-Hodgkin lymphomaDormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →